Cited by 498Cannabis and Cannabinoid ResearchAdenosine and Purinergic SignalingInflammatory mediators and NSAID effects

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression

Open access

Carrier, Erica J., Auchampach, John A., Hillard, Cecilia J.·2006·Proceedings of the National Academy of Sciences

Open this paper in CoChat — free account Open PDF

Abstract

The plant-derived cannabinoids delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD) both have immunosuppressive effects; although some effects of THC are mediated by the CB2 receptor, CB2 binds CBD weakly. In examining the effects of THC and CBD on microglial proliferation, we found that these compounds potently inhibit [3H]thymidine incorporation into a murine microglial cell line with no effect on cell cycle. Treatment with THC and CBD decreased [3H]thymidine uptake into microglia, with IC50 values that match inhibition of [3H]thymidine incorporation into DNA. CBD and, less potently, THC decreased uptake of [3H]adenosine to a similar extent as [3H]thymidine in both murine microglia and RAW264.7 macrophages. Binding studies confirm that CBD binds to the equilibrative nucleoside transporter 1 with a Ki < 250 nM. Because adenosine agonists have antiinflammatory effects, and because uptake of adenosine is a primary mechanism of terminating adenosine signaling, we tested the hypothesis that CBD is immunosuppressive because it enhances endogenous adenosine signaling. In vivo treatment with a low dose of CBD decreases TNFalpha production in lipopolysaccharide-treated mice; this effect is reversed with an A2A adenosine receptor antagonist and abolished in A2A receptor knockout mice. These studies demonstrate that CBD has the ability to enhance adenosine signaling through inhibition of uptake and provide a non-cannabinoid receptor mechanism by which CBD can decrease inflammation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.0511232103

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Reactive microgliosis
Streit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096
Adenosine: an endogenous regulator of innate immunity
Haskó, G. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 900
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1082oa · Cited by 589
Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients
Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R. J., Sanvito, W. L., Lander, N., & Mechoulam, R. (2008) · Pharmacology · doi:10.1159/000137430 · Cited by 570
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
Buckley, N. E., McCoy, K. L., Mezey, É., Bonner, T. I., Zimmer, A. M., Felder, C. C., Glass, M., & Zimmer, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00211-9 · Cited by 546
The cannabinoid system and immune modulation
Klein, T., Newton, C. A., Larsen, K. A., Lu, L. D., Perkins, I., Nong, L., & Friedman, H. P. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303101 · Cited by 533
Cannabidiol: An Overview of Some Pharmacological Aspects
Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 530

Flagged first, then by citations

Show all 39 references

Research works printed but not linked: 7

R. K. Razdan Pharmacol. Rev 38, 75–149 (1986).
R. G. Pertwee Cannabinoids, ed V. Di Marzo (Kluwer Academic/Plenum Publishers, New York), pp. 32–83 (2004).
A. C. Howlett, J. M. Qualy, L. L. Khachatrian Mol. Pharmacol 29, 307–313 (1986).
B. Desoize, C. Leger, J. C. Jardillier, G. Nahas Adv. Biosci 22–23, 145–159 (1978).
B. Desoize, C. Leger, G. Nahas C. R. Hebd. Seances Acad. Sci. D 287, 1441–1444 (1978).
P. G. Smith, H. D. Thomas, H. C. Barlow, R. J. Griffin, B. T. Golding, H. Calvert, D. R. Newell, N. J. Curtin Clin. Cancer Res 7, 2105–2113 (2001).
A. S. Gordon, L. Nagy, D. Mochly-Rosen, I. Diamond Biochem. Soc. Symp 56, 117–136 (1990).

Sorted by citations

Items 301–400 of 498

Cannabinoids – a new therapeutic strategy in neurology
Sîrbu, C. A., Manole, A. M., Vasile, M., Toma, G. S., Dobrican, L. R., Varvara, D. G., & Vasiliu, O. (2022) · Romanian Journal of Military Medicine · doi:10.55453/rjmm.2022.125.3.1 · Cited by 16
Effect of Cannabinoids upon the Uptake of Folic Acid by BeWo Cells
Araújo, J. R., Gonçalves, P., & Martel, F. (2009) · Pharmacology · doi:10.1159/000192587 · Cited by 16
Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects
Hu, Z., Qin, Z., Xie, J., Qu, Y., & Yin, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116271 · Cited by 15
Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition
Marı́n, J. J. G., Cives-Losada, C., Macı́as, R. I. R., Romero, M. R., Marijuan, R. P., Hortelano-Hernandez, N., Delgado-Calvo, K., Villar, C., Santiago, J. M. G., Monte, M. J., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116166 · Cited by 14
Ion channels and G protein-coupled receptors: Cannabidiol actions on disorders of excitability and synaptic excitatory-inhibitory ratio
Tsien, R. W., & Rosenberg, E. C. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100017 · Cited by 14
On healthcare by popular appeal: critical assessment of benefit and risk in cannabidiol based dietary supplements
Cogan, P. S. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1612743 · Cited by 14
Inhibition of nucleoside transport and synergistic potentiation of methotrexate cytotoxicity by cimicifugoside, a triterpenoid from Cimicifuga simplex
Yawata, A., Matsuhashi, Y., Kato, H., Uemura, K., Kusano, G., Itô, J., Chikuma, T., & Hojo, H. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.08.011 · Cited by 14
Lack of a Significant Effect of Cannabinoids upon the Uptake of 2-Deoxy-D-Glucose by Caco-2 Cells
Gonçalves, P., Araújo, J. R., Azevedo, I., & Martel, F. (2008) · Pharmacology · doi:10.1159/000127408 · Cited by 14
Inhibition of the Equilibrative Nucleoside Transporter 1 and Activation of A2A Adenosine Receptors by 8-(4-Chlorophenylthio)-modified cAMP Analogs and Their Hydrolytic Products
Waidmann, O., Pleli, T., Dvorak, K., Baehr, C., Mondorf, U. F., Plotz, G., Biondi, R. M., Zeuzem, S., & Piiper, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056622 · Cited by 14
Update of the statement on safety of cannabidiol as a novel food
Nutrition, N. F. A. F. A. (. E. P. O., Turck, D., Bohn, T., Cámara, M., Castenmiller, J. J. M., Henauw, S. D., Jos, A. M., Maciuk, A., Mangelsdorf, I., McNulty, B. A., et al. (2026) · EFSA Journal · doi:10.2903/j.efsa.2026.9862 · Cited by 13
Differential role of adenosine signaling cascade in acute and chronic pain
Adebiyi, M. G., Manalo, J. M., Kellems, R. E., & Xia, Y. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134483 · Cited by 15
Cannabidiol: Science, Marketing, and Legal Perspectives
Wiley, J. L., Gourdet, C., & Thomas, B. F. (2020) · doi:10.3768/rtipress.2020.op.0065.2004 · Cited by 13
Plant-derived compounds and neurodegenerative diseases: Different mechanisms of action with therapeutic potential
Echeverry, C., Pazos, M., Torres‐Pérez, M., & Prunell, G. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.039 · Cited by 12
Regulation of Extracellular Adenosine
Boison, D. (2018) · Springer eBooks · doi:10.1007/978-3-319-90808-3_2 · Cited by 12
In Vitro Screening of Three Commercial Cannabis-Based Products on ATP-Binding Cassette and Solute-Carrier Transporter Function
Anderson, L. L., Etchart, M. G., MacNair, L., Land, M. H., Mosesova, I., Bonn‐Miller, M. O., & Arnold, J. C. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0053 · Cited by 12
Cannabidiol as a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development
Liou, G. I., El‐Remessy, A. B., Ibrahim, A. S., Caldwell, R. B., Khalifa, Y., Gunes, A., & Nussbaum, J. J. (2009) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/1875692110907030215 · Cited by 12
Intraperitoneal cannabidiol attenuates neonatal germinal matrix hemorrhage-induced neuroinflamation and perilesional apoptosis
Almeida, T., Santos, M. V., Lopes, L. D. S., Goel, G., de Freitas, R. L., de Medeiros, P. S., Crippa, J. A. S., & Machado, H. R. (2019) · Neurological Research · doi:10.1080/01616412.2019.1651487 · Cited by 12
Cannabidiol at Nanomolar Concentrations Negatively Affects Signaling through the Adenosine A2A Receptor
Raïch, I., Lillo, J., Ferreiro‐Vera, C., de Medina, V. S., Navarro, G., & Franco, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417500 · Cited by 11
A review of the direct targets of the cannabinoids cannabidiol, Δ9-tetrahydrocannabinol, N-arachidonoylethanolamine and 2-arachidonoylglycerol
Wright, N. J. D. (2024) · AIMS neuroscience · doi:10.3934/neuroscience.2024009 · Cited by 11
Therapeutic potential of CBD in Autism Spectrum Disorder
Pedrazzi, J. F. C., Hassib, L., Ferreira, F. R., Hallak, J. E. C., Del-Bel, E., & Crippa, J. A. S. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.05.002 · Cited by 12
The antitumor action of cannabinoids on glioma tumorigenesis.
Zogopoulos, P., Korkolopoulou, P. A., Patsouris, E., & Theocharis, S. E. (2015) · PubMed · doi:10.14670/hh-30.629 · Cited by 11
Neuromolecular Mechanisms of Cannabis Action
Adel, Y., & Alexander, S. P. H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_2 · Cited by 11
Distinct Effects of D9-tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
Fusar‐Poli, P. (2009) · European Psychiatry · doi:10.1016/s0924-9338(09)70439-0 · Cited by 11
A Novel Anti-Inflammatory Formulation Comprising Celecoxib and Cannabidiol Exerts Antidepressant and Anxiolytic Effects
Dinur, E., Goldenberg, H., Robinson, E., Naggan, L., Kozela, E., & Yirmiya, R. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0225 · Cited by 11
The latest advances in the pharmacological management of focal epilepsies in children: a narrative review
Matricardi, S., Scorrano, G., Prezioso, G., Burchiani, B., Cara, G. D., Striano, P., Chiarelli, F., & Verrottı, A. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2326606 · Cited by 10
Toxicological safety of VOHO Hemp Oil; a supercritical fluid extract from the aerial parts of hemp
Dziwenka, M. M., Dolan, L. C., & Mitchell, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261900 · Cited by 10
Cannabinoids Receptors in COVID-19: Perpetrators and Victims
Al-Kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A. T., & Batiha, G. E. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220829145029 · Cited by 10
Increasing cannabis use and importance as an environmental contaminant mixture and associated risks to exposed biota: A review
Kennedy, E. K. C., Perono, G. A., Nemez, D. B., Holloway, A. C., Thomas, P. J., Letcher, R. J., Märvin, C. H., Stetefeld, J., Stout, J. M., Peters, O., et al. (2020) · Critical Reviews in Environmental Science and Technology · doi:10.1080/10643389.2020.1819730 · Cited by 11
Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis
Navarrete, C. M., García‐Martín, A., DeMesa, J., & Muñóz, E. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01112-7 · Cited by 10
Cladribine as a Potential Object of Nucleoside Transporter-Based Drug Interactions
Hermann, R., Krajcsi, P., Fluck, M., Seithel‐Keuth, A., Bytyqi, A. H., Galazka, A. R., & Munafo, A. (2021) · Clinical Pharmacokinetics · doi:10.1007/s40262-021-01089-9 · Cited by 10
Safety of cannabis- and hemp-derived constituents in reproduction and development
Akingbasote, J. A., Szlapinski, S. K., Charrette, A., Hilmas, C. J., & Guthrie, N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89773-0.00024-2 · Cited by 10
Acute cannabidiol treatment reverses behavioral impairments induced by embryonic valproic acid exposure in male mice
Pedrazzi, J. F. C., Sales, A. J., Ponciano, R., Ferreira, L. G., Ferreira, F. R., Campos, A. C., Hallak, J. E. C., Zuardi, A. W., Bel, E. A. D., Guimarães, F. S., et al. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173919 · Cited by 10
Cannabidiol versus placebo as adjunctive treatment in early psychosis: study protocol for randomized controlled trial
Dixon, T., & Cadenhead, K. S. (2023) · Trials · doi:10.1186/s13063-023-07789-w · Cited by 9
Perfil antipsicótico do canabidiol
Pedrazzi, J. F. C., Pereira, A. C. D. C. I., Gomes, F. V., & Bel, E. A. D. (2014) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.v47i2p112-119 · Cited by 9
Conversation with Raphael Mechoulam
Mechoulam, R. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01795.x · Cited by 9
The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol
de Oliveira, B. S. A., Milanezi, D. S., Gonzaga, P. D. V., Detoni, F. R., & Soriano, R. N. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12172 · Cited by 10
Feeding treats containing cannabidiol (CBD) did not alter canine immune response to immunization with a novel antigen
Morris, E. M., Kitts-Morgan, S. E., Spangler, D. M., McLeod, K. R., Suckow, M. A., & Harmon, D. L. (2021) · Research in Veterinary Science · doi:10.1016/j.rvsc.2021.12.012 · Cited by 9
The influence cannabidiol on delayed onset of muscle soreness
Hatchett, A. G., Armstrong, K. E., Hughes, B., & Parr, B. B. (2020) · International Journal of Physical Education Sports and Health · Cited by 9
Chemotherapy-Induced Neuropathic Pain
Raffa, R. B., Langford, R. M., Pergolizzi, J. V., Porreca, F., & Tallarida, R. J. (2012) · CRC Press eBooks · doi:10.1201/b12366 · Cited by 10
The development and therapeutic potential of classical and next-generation cannabinoid ligands
Muñoz-Canales, V., Benhamú, B., Martín‐Fontecha, M., Vázquez‐Villa, H., & Ortega‐Gutiérrez, S. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108022 · Cited by 8
Epilepsy, neuroinflammation and cannabidiol What do we know thus far?
Ríos, G. P., Perucca, E., Striano, P., Caraballo, R. H., Ríos, X. P., Pascual, S. I. P., & Cuesta, G. B. P. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1749260 · Cited by 8
Adenosinergic system and nucleoside transporters in attention deficit hyperactivity disorder: Current findings
Valladão, S. C., França, A. P., Pandolfo, P., & dos Santos‐Rodrigues, A. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105771 · Cited by 8
Cannabidiol Modulates Neuroinflammatory and Estrogen-Related Pathways in a Sex-Specific Manner in a Chronic Stress Model of Depression
Bright, U., & Akirav, I. (2025) · Cells · doi:10.3390/cells14020099 · Cited by 8
Do Adenosine Receptors Offer New Therapeutic Options for Diabetic Nephropathy?
Martín, R. S., Valladares-Ide, D., Roa, H., Troncoso, E., & Sobrevía, L. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109789043964 · Cited by 8
Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors
Souza, A. J., Guimarães, F. S., & Gomes, F. V. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114504 · Cited by 8
Cannabinoids in the Management of Nausea and Vomiting
Parker, L. A., & Limebeer, C. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_13 · Cited by 8
Cannabidiol Prevents the Expression of the Locomotor Sensitization and the Metabolic Changes in the Nucleus Accumbens and Prefrontal Cortex Elicited by the Combined Administration of Cocaine and Caffeine in Rats
Prieto, J. P., López‐Hill, X., Urbanavicius, J., Sánchez, V., Nadal, X., & Scorza, C. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00218-9 · Cited by 8
Development and Characterization of a Microemulsion Containing a Cannabidiol Oil and a Hydrophilic Extract from Sambucus ebulus for Topical Administration
Areses-Huete, T., Córdoba-Díaz, D., Torres‐Suárez, A. I., & Córdoba-Díaz, M. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060705 · Cited by 7
The CB2 Receptor in Immune Regulation and Disease: Genetic Architecture, Epigenetic Control, and Emerging Therapeutic Strategies
Kalkan, H., & Flamand, N. (2025) · DNA · doi:10.3390/dna5040059 · Cited by 7
The Concept of an Epilepsy Brain Bank
Hernández‐Ronquillo, L., Mahabadi, H. M., Moien‐Afshari, F., Wu, A., Auer, R. N., Zherebitskiy, V. A., Borowsky, R., Mickleborough, M., Huntsman, R. J., Vrbancic, M. I., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00833 · Cited by 7
A Review of Sturge–Weber Syndrome Brain Involvement, Cannabidiol Treatment and Molecular Pathways
Joslyn, K. E., Truver, N. F., & Comi, A. M. (2024) · Molecules · doi:10.3390/molecules29225279 · Cited by 7
Between Science and Big Business: Tapping Mary Jane’s Uncharted Potential
Grotsch, K., & Fokin, V. V. (2022) · ACS Central Science · doi:10.1021/acscentsci.1c01100 · Cited by 7
Cannabidiol and the central nervous system: translating into clinics
Saviano, A., Raucci, F., Tallarico, M., Caro, C. D., Martino, S., Nesci, V., Roberti, R., Iannone, L. F., Colia, A. L., Dimonte, S., et al. (2021) · doi:10.36118/pharmadvances.2021.04 · Cited by 7
The effect of a long-term treatment with cannabidiol-rich hemp extract oil on the adenosinergic system of the zucker diabetic fatty (ZDF) rat atrium
Viczján, G., Szilágyi, A., Takács, B., Óvári, I., Szekeres, R., Tarjányi, V., Erdei, T., Teleki, V., Zsuga, J., Szilvássy, Z., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1043275 · Cited by 7
The Nucleoside Transporters CNTs and ENTs
Ho, H. T. B., & Wang, J. (2014) · Wiley eBooks · doi:10.1002/9781118705308.ch7 · Cited by 7
The Misclassification of Medical Marijuana.
Krystal, H. L. (2018) · PubMed · doi:10.29158/jaapl.003790-18 · Cited by 8
Cannabidiol reduces synaptic strength and neuronal firing in layer V pyramidal neurons of the human cortex with drug-resistant epilepsy
Martínez-Rojas, V. A., Márquez, L. A., Martínez-Aguirre, C., Sollozo-Dupont, I., López-Preza, F. I., Mejía, M. F., Alonso, M., Rocha, L., & Galván, E. J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1627465 · Cited by 6
The Use of Cannabis and Its Effects on Postpartum Depression
Ayisire, O. E., Okobi, O. E., Adaralegbe, N., Adeosun, A. A., Sood, D., Onyechi, N. P., Agazie, O., Shittu, H. O., Akinsola, Z., Nnaji, C. G., et al. (2022) · Cureus · doi:10.7759/cureus.27926 · Cited by 6
The Perspective of Cannabidiol in Psoriasis Therapy
Stănescu, A. M. A., Bejan, G. C., Baltă, M. D., Andronic, O., Toma, C. V., & Busnatu, Ș. (2024) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s469698 · Cited by 7
Cannabidiol As a Treatment for COVID-19 Symptoms? A Critical Review
Holst, M., Nowak, D., & Hoch, E. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0135 · Cited by 6
Cannabidiol’s Multifactorial Mechanisms Has Therapeutic Potential for Aneurysmal Subarachnoid Hemorrhage: a Review
Henry, N., Fraser, J. F., Chappell, J., Langley, T., & Roberts, J. (2022) · Translational Stroke Research · doi:10.1007/s12975-022-01080-x · Cited by 8
Can cannabidiol have an analgesic effect?
Kulesza, B., Mazurek, M., & Kurzepa, J. (2023) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12947 · Cited by 6
Role of integrating cannabinoids and the endocannabinoid system in neonatal hypoxic-ischaemic encephalopathy
Xiao, J., Zhou, Y., Sun, L., & Wang, H. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1152167 · Cited by 6
Targeting Astrocytomas and Invading Immune Cells with Cannabinoids: A Promising Therapeutic Avenue
Cudaback, E., & Stella, N. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0016-z · Cited by 6
Pharmacology of Cannabis
Srikantha, L., & Gonik, N. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-12998-8_21 · Cited by 6
Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to Therapy
Montebello, G., & Giovanni, G. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136234 · Cited by 6
Analysis of the cannabidiol effects in epilepsy treatment based on seizure characteristics in EEG recordings – A review
Kopańska, M., Ochojska, D., Trojniak, J., Kawala‐Sterniuk, A., Mikołajewski, D., Karwowski, W., Al‐Bakri, A. F., Sterniuk, P., & Szczygielski, J. (2025) · Epileptic Disorders · doi:10.1002/epd2.70085 · Cited by 5
Hemp essential oil: an innovative product with potential industrial applications
Mazzara, E., Petrelli, R., Torresi, J., Ricciardi, R., Benelli, G., & Maggi, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89867-6.00012-3 · Cited by 5
Effects of Cannabidiol on the Functions of Chimeric Antigen Receptor T Cells in Hematologic Malignancies
Chantarat, N., Pe, K. C. S., Suppipat, K., Vimolmangkang, S., & Tawinwung, S. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0108 · Cited by 5
Analgesic Properties of Next-Generation Modulators of Endocannabinoid Signaling: Leveraging Modern Tools for the Development of Novel Therapeutics
Singh, S. J., Ellioff, K. J., Bruchas, M. R., Land, B. B., & Stella, N. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.124.002119 · Cited by 5
Cannabinoids: Chemistry and Medicine
Appendino, G., & Taglialatela‐Scafati, O. (2013) · Springer eBooks · doi:10.1007/978-3-642-22144-6_147 · Cited by 5
Nonopioid Analgesics
Brogan, S. E., Mandyam, S., & Odell, D. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-48110-6.00019-3 · Cited by 5
THE NUCLEOSIDE TRANSPORTERS CNTs AND ENTs
Govindarajan, R., Quiñones, A. L., & Wang, J. (2022) · Wiley eBooks · doi:10.1002/9781119739883.ch8 · Cited by 5
A journey through cannabidiol in Parkinson’s disease
Del-Bel, E., Barros, N., de Moraes, R. A. P. D. S., de Mattos, B. A., Alves-Fernandes, T. A., de Abreu, L. B., Nascimento, G. C., Escobar-Espinal, D. M., Pedrazzi, J. F. C., Jacob, G. A., et al. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.015 · Cited by 4
Combination of CBD with minor cannabinoid CBDV suppresses CXCR4 via CB2 receptor and alleviates colitis in mice
Gelfand, A., Besser, E., Procaccia, S., Cohen, J., Steinberg, M., Kleifeld, O., & Meiri, D. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118768 · Cited by 4
Phytocannabinoids—Evaluation of their therapeutic role in neuroinflammation
Smith, S. L., Spurgeon, T., Spurgeon, R., & Heal, D. J. (2024) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2024.00087 · Cited by 4
Steroid hormones are novel nucleoside transport inhibitors by competition with nucleosides for their transporters
Kaneko, M., Hakuno, F., Kamei, H., Yamanaka, D., Chida, K., Minami, S., Coe, I. R., & Takahashi, S. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.132 · Cited by 4
Cannabidiol and Multiple Sclerosis
Mecha, M., Feliú, A., Carrillo-Salinas, F. J., & Guaza, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00108-3 · Cited by 4
Looking ahead after 50 years of research on cannabinoids
Mechoulam, R. (2014) · Wiley eBooks · doi:10.1002/9781118451281.ch1 · Cited by 4
Molecular targets of cannabinoids and their derivatives in epilepsy – a review with focus on CBD
Marciniak, S., Wasyluk, W., & Wojtak, A. (2025) · Acta Biochimica Polonica · doi:10.3389/abp.2025.15251 · Cited by 3
The phytocannabinoid cannabidivarin alleviates cognitive and social behaviour deficits in the sub-chronic phencyclidine rat model of relevance for schizophrenia
Grayson, B., Podda, G., Cilia, J., Woolley-Roberts, M., Neill, J. C., Fletcher, J., & Harte, M. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251381246 · Cited by 3
Characterisation of components of an extract of hemp and preliminary assessment of anti-inflammatory activity in an ex vivo model of bovine endometritis
Parveen, I., Allen, N. R., Wonfor, R. E., Al-Fadhli, A. A., Forde-Thomas, J., Giles, J. L., Walton, R. T., Threadgill, M. D., & Nash, D. M. (2025) · South African Journal of Botany · doi:10.1016/j.sajb.2025.03.007 · Cited by 3
Investigation in the CB1 and CB2 receptor binding profile and intrinsic activity of (−) and (+)-enantiomers of some naturally occurring phytocannabinoids or synthetic derivatives
Rodríguez-Carreiro, S., Gómez‐Cañas, M., Lubrini, F., Gonzalo‐Consuegra, C., Winkler, M., Caprioglio, D., Appendino, G., García, C., Morales, P., Jagerovic, N., et al. (2025) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2025.100262 · Cited by 3
Effects of cannabidiol (CBD) treatment on age-related cognitive decline in C57 mice
Agha, B. M., Monteith, M., Earl, J., Ganske, K., Kaloa, T., McDonald, K. J., Nixon, A. G., Panjwani, M., Robinson, D., Rusnak, V., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1567650 · Cited by 3
Cannabidiol as a Treatment for Seizures, Convulsions and Epilepsy
Thomas, B. F. (2017) · Springer eBooks · doi:10.1007/978-3-319-54564-6_11 · Cited by 3
Neuroprotection by the cannabis-related products, cannabidiol and cannabigerol, and their associated mechanisms of action
Echeverry, C., Fagetti, J., Reyes-Parada, M. I., & Scorza, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90036-2.00039-9 · Cited by 3
A Novel and Fast Purification Method for Nucleoside Transporters
Hao, Z., Thomsen, M., Postis, V. L. G., Lesiuk, A., Sharples, D. J., Wang, Y., Bartlam, M. G., & Goldman, A. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00023 · Cited by 3
In vivo phenotypic validation of adenosine receptor-dependent activity of non-adenosine drugs
Xiao, C., Gavrilova, O., Liu, N., Lewicki, S. A., Reitman, M. L., & Jacobson, K. A. (2023) · Purinergic Signalling · doi:10.1007/s11302-023-09924-3 · Cited by 3
Drug interactions with Cannabis sativa: Mechanisms and clinical implication
Hasanpoor, A., Akaberi, M., Kesharwani, P., Sobhani, Z., & Sahebkar, A. (2023) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2023.10.004 · Cited by 3
Daring discourse – yes: practical considerations for cannabis use in the perioperative setting
Clarke, H. A., Roychoudhury, P., Ladha, K. S., Leroux, T. S., Fiorellino, J., Huang, A., & Kotra, L. P. (2020) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2020-101521 · Cited by 3
The Development of Cannabidiol as a Psychiatric Therapeutic: A Review of Its Antipsychotic Efficacy and Possible Underlying Pharmacodynamic Mechanisms
Jalali, S. (2013) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2013/6192 · Cited by 3
Overview of Medicinal Cannabis
O’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_4 · Cited by 3
Immune cell exhaustion and apoptotic markers in major depressive disorder: Effects of in vitro cannabidiol administration
Rachayon, M., Jirakran, K., Sodsai, P., Tunvirachaisakul, C., Sughondhabirom, A., Li, J., Zhang, Y., & Maes, M. H. J. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101066 · Cited by 2
Low Abuse Potential of Plant-Derived Highly Purified Cannabidiol: A Narrative Review
Yamamoto, H., Dayal, S., Nortvedt, C., & Takumi, I. (2025) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.25-00086 · Cited by 2
Experimental and computational approaches for evaluating molecule interactions with equilibrative nucleoside transporters 1 and 2
Martinez-Guerrero, L., Vignaux, P. A., Farrera, D. O., Harris, J. S., Raman, R., Lane, T. R., Wright, S. H., Ekins, S., & Cherrington, N. J. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103660 · Cited by 2
Supercritical carbon dioxide Cannabis sativa L. and Humulus lupulus extracts and their influence on human macrophages inflammatory state*
Gregorius, A., Krzyczkowski, W., Wierucka, M., Kupińska, J., Dębczak, A., Łopatek, U., Tyśkiewicz, K., Wiejak, R., Wrona, O., & Rój, E. (2019) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0013.6827 · Cited by 2
L’usage du cannabidiol dans le sport : une bonne idée ?
Gamelin, F.-X., Berthoin, S., Cuvelier, G., Mendes, A., Anthierens, A., & Heyman, E. (2021) · Science & Sports · doi:10.1016/j.scispo.2021.03.003 · Cited by 2
Neurotoxic or Protective Cannabis Components: Delta-9-Tetrahydrocannabinol ( Δ9 THC) and Cannabidiol (CBD)
Silva, M. H. (2023) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2023.00017 · Cited by 3
Cannabinoid-based Pharmacology for the Management of Substance Use Disorders
Luján, M. Á., Kim, Y., Zhang, L., & Cheer, J. F. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_551 · Cited by 2
Cannabidiol (CBD) and Colorectal Tumorigenesis: Potential Dual Modulatory Roles via the Serotonergic Pathway
Liu, Z. (2025) · Current Oncology · doi:10.3390/curroncol32070375 · Cited by 2

Authors: Carrier, E. J., Auchampach, J. A., & Hillard, C. J.
Affiliations: Medical College of Wisconsin (US)
ORCID: Carrier, Erica J.
Auchampach, John A.
Hillard, Cecilia J.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2006-05-16
Volume: 103
Issue: 20
Pages: 7895-7900
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0511232103
OpenAlex: W2067960394
Cited by: 497
References: 39
Citations by year: 2026: 20 · 2025: 30 · 2024: 29 · 2023: 33 · 2022: 40 · 2021: 33 · 2020: 40 · 2019: 32 · 2018: 19 · 2017: 25 · 2016: 20 · 2015: 19 · 2014: 11 · 2013: 20 · 2012: 24
FWCI: 14.00
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Heart, Lung, and Blood Institute (HL 077707, R01HL077707)
National Institute on Drug Abuse (R01DA009155, DA 16967, DA09155, R01DA016967)
National Institute of Neurological Disorders and Stroke (NS041314, R01NS041314)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords: cannabidiol, delta-9-tetrahydrocannabinol, equilibrative nucleoside transporter 1, adenosine uptake, adenosine signaling, adenosine A2A receptor, microglial proliferation, macrophages, TNF-α, lipopolysaccharide-induced inflammation, anti-inflammatory activity
MeSH terms: Rimonabant, Adenosine, Animals, Camphanes, Cannabidiol, Cell Line, DNA, Immunosuppression Therapy, Lipopolysaccharides, Male, Mice, Inbred C57BL, Piperidines, Psychotropic Drugs, Pyrazoles, Dronabinol, Thymidine, Tumor Necrosis Factor-alpha, Microglia, Nucleoside Transport Proteins, Equilibrative Nucleoside Transporter 1, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks